Brainstorm Cell Therapeutics | BCLI - Ebit

Aktienkurs
0.89
Täglich Wechseln
-0.03 -3.24%
Monatlich
-0.77%
Jährlich
15.07%
Q2 Prognose
0.90




Ebit Veränderung Datum
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Biogen USD 659.6M 157M 2025-09
Brainstorm Cell Therapeutics USD -2.05M 526K 2025-09
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD 56.04M 63.94M 2025-12
CSL USD 2.64B 116M 2025-12
Cytokinetics USD -178.37M 11.61M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Mesoblast USD -27.75M 14.36M 2025-12